Skip to main content

Table 6 Documentation frequency of safety KPIs in SCM and the administrative databases

From: Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis

KPI

N (%)

Safety KPIs

Tuberculosis Screening

Number of patients with documentation of a TB test for a biologic start in SCM, Practitioner Claims, NACRS, or Consolidated Laboratory Repository [n = 56], n (%)

54 (96%)

  SCM [n = 56]

53 (95%)

  Practitioner Claims [n = 56]

18 (32%)

  NACRS [n = 56]

4 (7%)

  Consolidated Laboratory Repository [n = 56]

5 (9%)

 Number of patients screened for TB within 12 months prior to receiving a first course of therapy using a biologic DMARD [n = 56]

5 (9%)

  Practitioner Claims [n = 18]

3 (17%)

  NACRS [n = 4]

2 (50%)

  Consolidated Laboratory Repository [n = 5]

0

Laboratory monitoring for DMARDs

 Number of patients on methotrexate and leflunomide with documentation of toxicity monitoring in the Consolidated Laboratory Repository [n = 102]

102 (100%)

  0–1 month [n = 102]

60 (59%)

  1–4 months [n = 101]

85 (84%)

  4–8 months [n = 94]

85 (90%)

  8–12 months [n = 88]

77 (88%)

  12–16 months [n = 79]

70 (89%)

  16–20 months [n = 68]

53 (78%)

  20–24 months [n = 55]

42 (76%)

 Number of patients who received methotrexate and leflunomide and monitored for toxicity by clinical laboratory methods in the Consolidated Laboratory Repository during every eligible interval [n = 102]

29 (28%)

 Number of patients on methotrexate or leflunomide with mention of laboratory tests orderedb in SCM at every eligible visit [n = 99]a

22 (22%)

 Number of patients on methotrexate or leflunomide with mention of laboratory test resultsc in SCM at every eligible visit [n = 99]a

33 (33%)

  1. aDoes not include patients who began methotrexate or leflunomide at last visit and denominator is entire cohort. bMention of laboratory tests ordered includes documentation reporting specific tests, non-specific tests, and ordering no tests
  2. cMention of laboratory test results includes documentation reporting specific tests, missing/pending/not yet available tests, non-specific tests, and documentation that no recent tests were completed